Recent Advances in Multiple Myeloma: Applying Real-World Evidence to Clinical Practice - Episode 9

Comparing Combination Treatment Regimens in Transplant-Eligible NDMM

,

Matthew James Pianko, MD, provides an overview of the recently updated data from the GRIFFIN trial and the role of quadruplet versus triplet regimens in the treatment landscape of transplant-eligible newly diagnosed multiple myeloma.